Can Rechallenge Be Done Safely After Mild or Moderate Drug-induced Liver Injury?
Overview
Authors
Affiliations
Severe liver injury induced by minocycline in hepatitis B patient: a Case Report.
Wang R, Li Y, Xia X Front Pharmacol. 2025; 15:1516217.
PMID: 39749206 PMC: 11693611. DOI: 10.3389/fphar.2024.1516217.
Molecular mechanisms behind the inhibitory effects of ginsenoside Rg3 on hepatic fibrosis: a review.
Tian Z, Hu R, Wang Z, Wang Y, Li W Arch Toxicol. 2024; 99(2):541-561.
PMID: 39729114 DOI: 10.1007/s00204-024-03941-w.
Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI).
Brennan P, Cartlidge P, Manship T, Dillon J Frontline Gastroenterol. 2022; 13(4):332-336.
PMID: 35722609 PMC: 9186030. DOI: 10.1136/flgastro-2021-101886.
Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials.
Hey-Hadavi J, Seekins D, Palmer M, Coffey D, Caminis J, Abdullaev S Drug Saf. 2021; 44(6):619-634.
PMID: 33725335 PMC: 8184702. DOI: 10.1007/s40264-021-01051-5.
Drug-induced liver injury: recent advances in diagnosis and risk assessment.
Kullak-Ublick G, Andrade R, Merz M, End P, Benesic A, Gerbes A Gut. 2017; 66(6):1154-1164.
PMID: 28341748 PMC: 5532458. DOI: 10.1136/gutjnl-2016-313369.